⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

AN2 Therapeutics, Inc. Common Stock

$5.09
-0.53 (-9.43%)

Volume:

127.697K ($650.54K)

Market Capitalization:

$192.08M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

AN2 Therapeutics Market Segments

Regular Trading Hours

-0.30(-5.57%)
Open$5.39
Close$5.09
Low$5.06
Low Change-0.33 (-6.12%)
High$5.60
High Change+0.21 (+3.90%)
Range$0.54
Volume126.101K
Dollar Volume$641.85K

Premarket

+0.07(+1.30%)
Open$5.37
Close$5.44
Low$5.37
Low Change0.00 (0.00%)
High$5.50
High Change+0.13 (+2.42%)
Range$0.13
Volume1.596K
Dollar Volume$8.68K

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$5.61
Close$5.61
Low$5.61
Low Change0.00 (0.00%)
High$5.61
High Change+0.00 (+0.00%)
Range$0.00
Volume29.089K
Dollar Volume$163.19K

Regular Trading Hours Yesterday

-0.07(-1.23%)
Open$5.69
Close$5.62
Low$5.50
Low Change-0.19 (-3.34%)
High$5.86
High Change+0.17 (+2.99%)
Range$0.36
Volume264.33K
Dollar Volume$1.49M

Premarket Yesterday

*No Trades in Segment

AN2 Therapeutics News

There is no current news for this stock at the moment.

AN2 Therapeutics Top Trades

AN2 Therapeutics's top trade so far today returned +4.28%, while the top short trade returned -9.11%.

AN2 Therapeutics Moving Averages

5 Day Moving Average (SMA5)$5.48
10 Day Moving Average (SMA10)$5.18
20 Day Moving Average (SMA20)$5.29
50 Day Moving Average (SMA50)$5.53
100 Day Moving Average (SMA100)$5.08
200 Day Moving Average (SMA200)$3.80

AN2 Therapeutics Statistics

Average Volume (30 Days)247.6K
P/E Ratio (Current)-5.95
EPS (Current)-$0.96
Dividend Yield0.00%
Free Cash Flow-$30.68M
Cash Ratio7.94
Current Ratio14.32
Quick Ratio14.32
Debt to Equity0.00
Enterprise Value$171.16M
EV to EBITDA-4.41
EV to Sales—
Price to Book2.84
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-0.44%
Return on Equity-0.48%

AN2 Therapeutics Stock Splits

There have been no stock splits for AN2 Therapeutics (ANTX).

AN2 Therapeutics Dividends

There have been no dividends for AN2 Therapeutics (ANTX).